User menu

Comparison between bacillus Calmette-Guerin and the A60 mycobacterial antigen complex used as cancer-preventive immunotherapies

Bibliographic reference Maes, H. ; Taper, Henryk ; Cocito, Carlo. Comparison between bacillus Calmette-Guerin and the A60 mycobacterial antigen complex used as cancer-preventive immunotherapies. In: Journal of Cancer Research and Clinical Oncology, Vol. 122, no. 5, p. 296-300 (1996)
Permanent URL
  1. Abramowsky C, Gonzalez B, Soensen RU (1993) Disseminated bacillus Calmette-Guérin infections in patients with primary immunodeficiencies. Am J Clin Pathol 100:52?56
  2. Bennett JA, Gruff H, McKeally MF, Zelterman D, Crispen RG (1983) Differences in biological activity among batches of lyophilized Tice bacillus Calmette-Guérin and their association with clinical course in stage I lung cancer. Cancer Res 43:4183?490
  3. Beschin A, Brijs L, De Baetselier P, Cocito C (1991) Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex. Eur J Immunol 21:793?797
  4. Besnard M, Sauvion S, Offredo C, Gaudelus J, Gaillard J-L, Veber F, Blanche S (1993) Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children. Pediatr Infect Dis J 12:993?997
  5. Borsas T, Rapp HJ (eds) (1973) Conference on the use of BCG in therapy of cancer. Natl Cancer Inst Monogr 39
  6. Chan J, Fujiwara T, Brennan P, McNeil M, Turco SJ, Sibille J-C, Snapper M, Aisen P, Bloom BR (1989) Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci USA 86:2453?2457
  7. Closs O, Harboe M, Axelsen NH, Burch-Christensen K, Magnusson M (1980) The antigen ofMycobacterium bovis, strain BCG, studied by cross immunoelectrophoresis: a reference system. Scand J Immunol 12:249?263
  8. Cocito C, Vanlinden F (1986) Preparation and properties of antigen A60 fromMycobacterium bovis BCG. Clin Exp Immunol 66:262?272
  9. Cocito C, Vanlinden F (1995) Composition and immunoreactivity of the A60 complex and other cell wall fractions fromMycobacterium bovis BCG. Scand J Immunol 41:179?187
  10. Cocito C, Baelden MC, Benoit C (1987) Immunological properties of antigen 60 of BCG: induction of humoral and cellular immune reactions. Scand J Immunol 25:579?585
  11. Coetsier C, Baelden MC, Coene M, Cocito C (1994) Immunological analysis of the components of the antigen complex A60 ofMycobacterium bovis BCG. Clin Diag Lab Immunol 1:139?144
  12. De Baetselier P, Kapon A, Katzav S, Tzehoval E, Dekegel D, Segal S, Feldman M (1980) Antigen induced proliferation assay for rabbit T lymphocytes. I. Characteristics of response. Immunology 41:997?1003
  13. Geran RI, Greenberg NH, MacDonald MM, Schumacher AM, Abbott BJ (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems, 3rd edn. Cancer Chemother Rep Part 3 3:29?32, 47?52
  14. Gilot P, Coene M (1994) Thermostable macromolecular antigens from mycobacteria. Can J Microbiol 40:605?611
  15. Hubbard RD, Ilory CM, Collins IM, Cocito C (1992) Immunization of mice with the A60 ofMycobacterium bovis BCG. Clin Exp Immunol 88:129?131
  16. Kristjansson M, Green P, Manning HL, Slutsky AM, Brecher SM, von Reyn CF, Arbeit RD, Maslow JN (1993) Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis 17:228?230
  17. Kung JF, Brooks SB, Jakway JP, Leonard LL, Talmage DW (1977) Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J Exp Med 146:665?672
  18. Maes H, Taper H, Cocito C (1995) Alteration of the immune response during cancer development and prevention by a mycobacterial antigen. Scand J Immunol 41:53?64
  19. Morales A (1984) Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer. J Urol 132:457?459
  20. Oldham RK, Weese JL, Herberman RB, Perlin E, Mills M, Heims W, Blom J, Green D, Reid J, Bellinger S, Law I, McCoy JL, Dean JH, Cannon GB (1976) Immunological monitoring and immunotherapy in carcinoma of the lung. Int J Cancer 18:739?749
  21. Palayew M, Briedis D, Libman M, Michel RP, Levy RD (1993) Disseminated infection after intravesical BCG immunotherapy. Detection of organisms in pulmonary tissue. Chest 104:307?309
  22. Rockwell SC, Kallmn RF, Fajardo LP (1972) Characteristics of a serially transplanted mouse mammary tumor and its tissue-cultureadapted derivative. J Natl Cancer Inst 49:735?749
  23. Sibley LD, Hunter SW, Brennan PJ, Krahenbuhl JL (1988) Mycobacterial lipoarabinomannan inhibits interferon-mediated activation of macrophages. Infect Immun 56:1232?1236